欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0486/002
药品名称Lercanidipina Mepha
活性成分
    • Lercanidipine hydrochloride 20.0 mg
剂型Film-coated tablet
上市许可持有人Ex_RMS DK/H/1489 Mepha - Investigação, Desenvolvimento e Fabricação Farmacêutica, Lda. PRT Lagoas Park, Edifício 5 A - Piso 2 Porto Salvo
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    许可日期2010/11/23
    最近更新日期2024/09/11
    药物ATC编码
      • C08CA13 lercanidipine
    申请类型
    • TypeLevel1：Abridged
    • TypeLevel2：Additional Strength/Form
    • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
    • TypeLevel4：Chemical Substance
    • TypeLevel5：Prescription Only
    附件文件下载
      市场状态Positive
      ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase